Introducing way more signals! We've added more signal sources to capture the full customer journey.

Learn More!
Arvelle Therapeutics

Arvelle Therapeutics

Founded in 2019, Arvelle Therapeutics is a company that specializes in the development and commercialization of carbamate, an investigational anti-seizure medication. Arvelle Therapeutics is located in Switzerland.

Last updated on

About Arvelle Therapeutics

Estimated Revenue

$10M-$50M

Employees

51-250

Funding / Mkt. Cap

$208M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

SIC Code

28

NAICs Code

32541

Location

City

Zug

State

Zug

Country

Switzerland
Arvelle Therapeutics

Arvelle Therapeutics

Find your buyer within Arvelle Therapeutics

Tech Stack (0)

search